RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GTHX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

G1 Therapeutics Inc stock downgraded to Buy Candidate
(Updated on Mar 28, 2024)

Buy candidate since Mar 21, 2024 Gain 16.76% PDF

The G1 Therapeutics Inc stock price fell by -3.36% on the last day (Thursday, 28th Mar 2024) from $4.47 to $4.32. During the last trading day the stock fluctuated 8.35% from a day low at $4.30 to a day high of $4.66. The price has risen in 8 of the last 10 days and is up by 38.46% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -623 thousand shares and in total, 935 thousand shares were bought and sold for approximately $4.04 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.89% during the next 3 months and, with a 90% probability hold a price between $2.23 and $5.05 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GTHX Signals & Forecast

The G1 Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.05 and $3.32. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -3.36%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for G1 Therapeutics Inc stock

On the downside, the stock finds support just below today's level from accumulated volume at $3.79 and $3.43. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, G1 Therapeutics Inc finds support just below today's level at $3.79. If this is broken, then the next support from accumulated volume will be at $3.43 and $3.33.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.359 between high and low, or 8.35%. For the last week, the stock has had daily average volatility of 9.61%.

Our recommended stop-loss: $4.11 (-4.98%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (GTHX) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect G1 Therapeutics Inc to open at $4.43, and during the day (based on 14 day Average True Range), to move between $3.97 and $4.67, which gives a possible trading interval of +/-$0.355 (+/-8.22%) up or down from last closing price. If G1 Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 16.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $4.47 (3.47%) than the support at $3.79 (12.27%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is G1 Therapeutics Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for G1 Therapeutics Inc stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 2.705 Buy Candidate Downgraded

Predicted Opening Price for G1 Therapeutics Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$4.43 ( 2.46%) $4.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GTHX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.79 10.78 %
R2 4.65 7.60 %
R1 4.56 5.64 %
Current price: 4.32
Support S1 4.29 -0.713 %
S2 4.20 -2.68 %
S3 4.07 -5.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.70 8.80 %
R2 4.54 5.09 %
R1 4.47 3.47 %
Current price 4.32
Support S1 3.79 -12.27%
S2 3.43 -20.60%
S3 3.33 -22.92%

FAQ

What is the symbol for G1 Therapeutics Inc Stock and on which exchange is it traded?
The symbol for G1 Therapeutics Inc is GTHX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell G1 Therapeutics Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for G1 Therapeutics Inc stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

How to buy G1 Therapeutics Inc Stock?
G1 Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy G1 Therapeutics Inc Stock.

What's the current price of G1 Therapeutics Inc Stock?
As of the end of day on the 2024-03-28, the price of an G1 Therapeutics Inc (GTHX) share was $4.32.

What is the 52-week high and low for G1 Therapeutics Inc Stock?
The 52-week high for G1 Therapeutics Inc Stock is $4.99 and the 52-week low is $1.08.

What is the market capitalization of G1 Therapeutics Inc Stock?
As of the 2024-03-28, the market capitalization of G1 Therapeutics Inc is 223.935M.

When is the next earnings date for G1 Therapeutics Inc?
The upcoming earnings date for G1 Therapeutics Inc is May 01, 2024.
Click to get the best stock tips daily for free!

About G1 Therapeutics Inc

G1 Therapeutics G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer... GTHX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT